Lycia Therapeutics, Inc. (LYCA) insider activity
Lycia Therapeutics, Inc. (LYCA): 3 insider buys worth $37,653,863 and 0 sales reported in the last 90 days.
- A 10%+ shareholder bought $1,059,396 of Lycia Therapeutics, Inc. stock with their own money. That is a big personal bet. (2026-10-27)
- A 10%+ shareholder bought $35,222,791 of Lycia Therapeutics, Inc. stock with their own money. That is a big personal bet. (2026-10-27)
- A 10%+ shareholder bought $1,371,676 of Lycia Therapeutics, Inc. stock with their own money. That is a big personal bet. (2026-10-27)
| Reported | Who | Stock | What | Amount | Source |
|---|
| 2026-10-27 | Venrock Healthcare Capital Partners III, L.P.
10% owner | LYCA
Lycia Therapeutics, Inc. | Bought | $1,059,396 | SEC filing |
| 2026-10-27 | Venrock Healthcare Capital Partners III, L.P.
10% owner | LYCA
Lycia Therapeutics, Inc. | Bought | $35,222,791 | SEC filing |
| 2026-10-27 | Venrock Healthcare Capital Partners III, L.P.
10% owner | LYCA
Lycia Therapeutics, Inc. | Bought | $1,371,676 | SEC filing |
All insider buys · Legends
TradeTrack shows public SEC filings for general information. It is not investment advice, an offer or a recommendation. Insiders buy and sell for many reasons, past results do not predict future results, and you can lose money.